Log in
NASDAQ:DNLI

Denali Therapeutics SEC Filings & 10K Form

$46.14
+0.26 (+0.57 %)
(As of 10/28/2020 12:00 AM ET)
Add
Compare
Today's Range
$43.59
Now: $46.14
$47.17
50-Day Range
$30.46
MA: $38.53
$45.88
52-Week Range
$12.39
Now: $46.14
$47.17
Volume777,139 shs
Average Volume642,201 shs
Market Capitalization$4.89 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.82

SEC Filings

Denali Therapeutics (NASDAQ:DNLI) SEC Filings

DateFilerForm TypeView
10/13/2020
5:45 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/07/2020
7:33 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2020
3:30 PM
BIOGEN INC. (Reporting)
Biogen MA Inc. (Reporting)
Denali Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/28/2020
3:11 PM
BIOGEN INC. (Filed by)
Denali Therapeutics (Subject)
Form SC 13G
09/14/2020
8:38 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
7:38 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
7:37 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
7:37 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
5:20 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
5:19 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
5:17 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
5:14 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
3:34 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2020
3:32 PM
Denali Therapeutics (Filer)
Form 8-K/A
08/14/2020
3:50 PM
AKDL, L.P. (Reporting)
BRATTON DOUGLAS K (Reporting)
Crestline Investors, Inc. (Reporting)
Crestline Management, LP (Reporting)
Crestline SI , L.P. (0001626597) (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
3:52 PM
Denali Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2020
3:43 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
7:51 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2020
6:17 PM
Bratton Capital Inc. (Reporting)
Bratton Capital Management, L.P. (Reporting)
BRATTON DOUGLAS K (Reporting)
Denali Therapeutics (Issuer)
Neuro Line Partners LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2020
4:41 PM
Bratton Capital Inc. (Reporting)
Bratton Capital Management, L.P. (Reporting)
BRATTON DOUGLAS K (Reporting)
Denali Therapeutics (Issuer)
Neuro Line Partners LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
8:42 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
8:41 PM
Denali Therapeutics (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
3:46 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2020
5:03 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
5:02 PM
Denali Therapeutics (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
5:02 PM
Denali Therapeutics (Issuer)
NELSEN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
5:01 PM
Denali Therapeutics (Issuer)
Klein Peter S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
5:00 PM
Denali Therapeutics (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
5:00 PM
Denali Therapeutics (Issuer)
FLATLEY JAY T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:59 PM
Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:58 PM
Cole Douglas G. (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2020
3:38 PM
Denali Therapeutics (Filer)
Form DEFA14A
04/02/2020
3:34 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2020
5:19 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2020
5:19 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2020
5:18 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2020
5:17 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2020
5:16 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4/A
04/01/2020
5:15 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4/A
04/01/2020
5:14 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4/A
04/01/2020
5:14 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4/A
02/27/2020
4:17 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2020
3:52 PM
ARCH Venture Fund VIII, L.P. (Filed by)
Denali Therapeutics (Subject)
Form SC 13G/A
02/13/2020
3:18 PM
Denali Therapeutics (Subject)
Flagship Ventures Fund V, L.P. (Filed by)
Form SC 13G/A
02/12/2020
5:03 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
5:03 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
5:02 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2020
5:01 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2020
1:19 PM
BlackRock Inc. (Filed by)
Denali Therapeutics (Subject)
Form SC 13G/A
01/29/2020
3:24 PM
Denali Therapeutics (Filer)
Form 424B5
01/27/2020
4:13 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2020
4:12 PM
Denali Therapeutics (Filer)
Form 424B5
01/16/2020
9:41 AM
BAILLIE GIFFORD & CO (Filed by)
Denali Therapeutics (Subject)
Form SC 13G/A
01/14/2020
8:04 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2019
6:35 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2019
4:16 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2019
3:29 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
5:17 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
4:08 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
3:36 PM
Denali Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
3:32 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2019
4:05 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
3:38 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
5:51 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
6:49 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
6:49 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
6:48 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
7:49 PM
Denali Therapeutics (Issuer)
NELSEN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
7:47 PM
ARCH Venture Fund VIII, L.P. (Reporting)
ARCH Venture Partners VIII, L.P. (Reporting)
ARCH Venture Partners VIII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
5:35 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
3:54 PM
Denali Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
3:33 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2019
4:08 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2019
4:07 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:47 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
5:14 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
5:13 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
4:15 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
6:30 PM
Denali Therapeutics (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
4:15 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
4:00 PM
Denali Therapeutics (Issuer)
NELSEN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
5:43 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
5:39 PM
Denali Therapeutics (Issuer)
Klein Peter S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
5:38 PM
Denali Therapeutics (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
5:36 PM
Denali Therapeutics (Issuer)
FLATLEY JAY T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
5:34 PM
Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
5:28 PM
Cole Douglas G. (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2019
4:52 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
4:37 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
4:34 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4/A
05/08/2019
3:36 PM
Denali Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
3:33 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
5:30 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2019
3:38 PM
Denali Therapeutics (Filer)
Form DEFA14A
04/18/2019
3:36 PM
Denali Therapeutics (Filer)
Form DEF 14A
04/11/2019
4:29 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
8:27 PM
Bratton Capital Inc. (Reporting)
Bratton Capital Management, L.P. (Reporting)
BRATTON DOUGLAS K (Reporting)
Denali Therapeutics (Issuer)
Neuro Line Partners LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
4:08 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
6:03 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
6:02 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.